women in anp - a baseline assessment
TRANSCRIPT
-
8/11/2019 Women in ANP - A Baseline Assessment
1/73
"#$%&'()*&' +,-.(/ +0.(/1 23)3&4/% 54$&'(6&*(0'
738*39-34 :;3/* 23804*
!"#$% '% ()*+,% -,.'"%,/ 0"/'1$2( 3,4$/'%$ (44$44#$%.
-
8/11/2019 Women in ANP - A Baseline Assessment
2/73
???@&8840@04$@ 3/* I+0.(/3?093' J3'*04)%(8+40>3/*K L+MJ+N@ " /0')04*(,9 0# #(O3 04$&'(6&*(0')P /004B('&*3B -1 "++25P ?04Q3B *0$3*%34 *03)*&-.()% *%3 /,443'* /%&..3'$3) #&/3B -1 ?093' (' "#$%&' D&*(0'&. +0.(/3 &'B B3O()3 ?&1) (' ?%(/%
*%3)3 /%&..3'$3) /0,.B -3 0O34/093@ A%3 /0')04*(,9 939-34) ?343R "++25P "#$%&' M093'S) 7Q(..)E3O3.0893'* T3'*34 L"M7ETNP U,)*(/3 #04 "..P J3B(/& "#$%&'()*&'P &'B M093' #04 "#$%&' M093'LM"MN@ A%3 8,480)3 0# *%() -&)3.('3 ?&) *0 B0/,93'* /%&..3'$3) &'B ('O(*3 ),$$3)*(0') &'B43/0993'B&*(0') -1 80.(/3?093' &'B 0*%34 Q31 ('B(O(B,&.) 0' %0? *0 (9840O3 *%3 ?04Q('$/0'B(*(0') 0# ?093' (' "D+ &'B .&1 & #(49 #0,'B&*(0' #04 ('/43&)('$ &'B ),)*&('('$ *%3 ',9-34 0#80.(/3?093' '&*(0'&..1@ A%3 )(*3) 0# *%() 840>3/* ?343 U&.&.&-&BP V34&*P W&-,.P W,'B,6P &'B J&6&4X3X7%&4(#@
(8"9. .+$ :$4$,;1+$;4A%3 "++25 43)3&4/% *3&9 43)80')(-.3 #04 *%() &))3))93'* ?343P (' &.8%&-3*(/&. 04B34P "%9&B7%&%334 "'(.P D&)$,. W&4(9(P J&(4& W,8834P H&4(B D&)341P 7&33B +&4*0P Y%)&' 7&&B&*P J0%&99&B7&-(4P Z&4$%0'& 7&(#(P &'B J0%)(' C)1&'P &'B [)9&(. Z&%(B(@
"%9&B 7%&%334 "'(.P J&(4& W,8834P &'B 7&33B +&4*0 &,*%043B *%() 43804*@
"++25 () $4&*3#,. *0 &.. $0O34'93'*&. &'B '0'X$0O34'93'*&. ('B(O(B,&.) ?%0 &$433B *0 -3('*34O(3?3B #04 *%() 43)3&4/% &'BF04 8&4*(/(8&*3B (' *%3 #0/,) $40,8 B()/,))(0')@ "++25 ()8&4*(/,.&4.1 ('B3-*3B *0 7,6&'& +&Q.&4 0# CDE+FG5AH" #04 %34 ),8804* &'B $,(B&'/3 *%40,$%0,* *%3840>3/* &'B *%3 T0')04*(,9 939-34 04$&'(6&*(0') #04 *%3(4 *(43.3)) 3##04*) (' &))()*('$ 80.(/3?093'*0 0O34/093 *%3(4 9&'1 /%&..3'$3)@
(8"9. (00:3/* A3&9[T ['*34'&*(0'&. T099,'(*1[T+T2 ['*34'&*(0'&. T0O3'&'* 0' +0.(*(/&. &'B T(O(. 2($%*)[+Tb ['*34'&*(0'&. +0.(/3 T004B('&*(0' b0&4B[+J ['*3$4&*3B +0.(/('$ J())(0'[7"H ['*34'&*(0'&. 73/,4(*1 "))()*&'/3 H04/3UTJb U0('* T004B('&*(0' &'B J0'(*04('$ b0&4BUH"5 U,)*(/3 #04 ".. 54$&'(6&*(0'U77+ U,)*(/3 73/*04 7,8804* +40$4&993G5AH" G&? &'B 54B34 A4,)* H,'B c "#$%&'()*&'J3B(/& J3B(/& "#$%&'()*&'J0T[A J('()*41 0# T099,'(/&*(0' &'B ['#049&*(0' A3/%'0.0$1J0[ J('()*41 0# ['*34(04 "##&(4)J0[T J('()*41 #04 ['#049&*(0' &'B T,.*,43J0U J('()*41 0# U,)*(/3J0M" J('()*41 0# M093' "##&(4)D"+M" D&*(0'&. "/*(0' +.&' #04 *%3 M093' 0# "#$%&'()*&'DT5 D0' /099())(0'3B 0##(/34DAJX" D"A5 A4&('('$ J())(0' #04 "#$%&'()*&'+E +0.(/3 E()*4(/*
-
8/11/2019 Women in ANP - A Baseline Assessment
5/73
???@&8840@04$@ =
+MJ+ +0.(/3 M093' J3'*04)%(8 +40>3/*772 73/,4(*1 73/*04 23#049CD C'(*3B D&*(0')CD"J" +"C C'(*3B D&*(0') "))()*&'/3 J())(0' *0 "#$%&'()*&' +0.(/3 "BO()041 C'(*CDE+FG5AH" C'(*3B D&*(0') E3O3.0893'* +40$4&9 F G&? &'B 54B34 A4,)* H,'B c
"#$%&'()*&'CDH+" C'(*3B D&*(0') +08,.&*(0' H,'B #04 "#$%&'()*&'CD7T2 C'(*3B D&*(0') 73/,4(*1 T0,'/(. 23)0.,*(0'a"M a(0.3'/3 "$&(')* M093'M"M M093' #04 "#$%&' M093'
-
8/11/2019 Women in ANP - A Baseline Assessment
6/73
???@&8840@04$@ d
CD$19.'@$ E9##,;F
V()*04(/&..1P &,*%04(*&4(&' 4,.3 /09-('3B ?(*% ('*349(**3'* 834(0B) 0# /0'#.(/* &'B /(O(. ?&4 %&)/43&*3B & '3$&*(O3 (9&$3 0# *%3 80.(/3 (' "#$%&'()*&'@ 7('/3 :;;< 73/,4(*1 73/*04 23#049 L772N
%&) 3'*&(.3B & ',9-34 0# '&*(0'&. &'B ('*34'&*(0'&. ('(*(&*(O3) *0 43#049 &'B ('/43&)3 *%3 )(63 0#
*%3 "#$%&' D&*(0'&. +0.(/3 L"D+N &'B ('/43&)3 *%3 3##3/*(O3'3)) 0# 80.(/('$ (' "#$%&'()*&'@
A%3 9&(' *?0 )*43&9) (' 772 ('(*(&*(O3) &43 *%3 ^349&' ^0O34'93'* F Y,4083&' C'(0' +0.(/3
J())(0' (' "#$%&'()*&' LYC+5GN &'B *%3 D"A5 A4&('('$ J())(0' c "#$%&'()*&' F T09-('3B
73/,4(*1 A4&')(*(0' T099&'B c "#$%&'()*&' LDAJX"FT7ATX"N@ M%343&) *%3 ^349&'FYC+5G
&8840&/% () 0'3 0# ('/43&)('$ *%3 43)80')(O3'3)) 0# *%3 80.(/3 *0?&4B) /099,'(*(3)S '33B)P *%3
DAJX"FT7ATX" &8840&/% () #0/,)3B 0' -,(.B('$ *%3 9(.(*&41 /&8&/(*1 0# *%3 "#$%&' D&*(0'&.
+0.(/3 L"D+N *0 9&Q3 *%3 80.(/3 -3**34 8438&43B #04 #($%*('$ ('),4$3'/(3)@ A%3 9&''34 (' ?%(/%
*%3)3 *?0 &8840&/%3) %&O3 -33' /004B('&*3BP %0?3O34P () .3)) *%&' 3##(/(3'* 04 3##3/*(O3@ ")(B3
#409 *%3 /43&*(0' 0# *%3 ['*34'&*(0'&. +0.(/3 T004B('&*(0' b0&4B L[+TbNP *%343 () .(**.3 3O(B3'/3
0# /00834&*(0' &'B /004B('&*(0'P 43),.*('$ (' /0'*4&B(/*041 840/3))3) &'B ,'),)*&('&-.3
0,*/093)@
A%3)3 /0'*4&B(/*(0') ,'B348(' *%3 #('B('$) 43804*3B (' *%() -&)3.('3 )*,B1 0' *%3 /0'B(*(0') 0#
80.(/3?093' (' "D+@ A%3 43804* (B3'*(#(3) /%&..3'$3) &'B 80))(-.3 93&),43) *%&* /0,.B -3
*&Q3' *0 ),8804* *%3 80)(*(0' 0# ?093' ?04Q('$ (' "D+@ A%3 .&/Q 0# #39&.3 .3&B34) (' "D+ ()
#43\,3'*.1 /(*3B &) 0'3 0# *%3 9&>04 0-)*&/.3) *0 ?093'S) &BO&'/393'* (' "D+@ A%3
('),##(/(3'/1 (' ',9-34 0# )3'(04 #39&.3 80.(/3 834)0''3. () /0980,'B3B -1 *%3 .3)) *%&'
*4&')8&43'* 43/4,(*93'* &'B 84090*(0' )1)*39)P &'B #,4*%34 /0980,'B3B -1 .3)) *%&'
&B3\,&*3 840O()(0') #04 ?093' c ('/.,B('$ & .&/Q 0# -&)(/ 840O()(0') ),/% &) ,'(#049) 04
),##(/(3'* &'B &B3\,&*3 )&'(*&41 #&/(.(*(3)@ [* %&) *0 -3 '0*3B *%&* ?%(.3 .&/Q 0# -&)(/ 840O()(0')#3/*) -0*% #39&.3) &'B 9&.3) (' "D+P #39&.3) ),##34 8&4*(/,.&4.1 &'B 9,/% 9043 /0')()*3'*.1
*%&' 93'@
A%3 438,*&*(0' 0# ?093' (' 80.(/3 () 90)*.1 '3$&*(O3 &'B &/*) &) & B3*3443'* *0 *%3 9043
3B,/&*3B &'B /&4334X04(3'*3B ?093' ?()%('$ *0 >0(' "D+P &.*%0,$% *%343 &43 )093 '0*&-.3
-
8/11/2019 Women in ANP - A Baseline Assessment
7/73
???@&8840@04$@ e
3f/38*(0')@ +0.(/3 /099&'B34) &'B .0/&. 3.B34) &43 ('/43&)('$.1 43/0$'(6('$ *%3 '3/3))(*1 0#
%&O('$ 9043 ?093' (' "D+ -3/&,)3 0# *%3 80)(*(O3 /0'*4(-,*(0') 9&B3 -1 & ',9-34 0#
80.(/3?093' (' .0/&. /099,'(*(3)@ A%3)3 /0'*4(-,*(0') ('/.,B3 ?093' -3('$ -0B1X)3&4/%3B -1
80.(/3?093'P /4(93) /099(**3B -1 ?093' -3('$ ('O3)*($&*3B -1 #39&.3 0##(/34)P &'B %093)
?(*% ?093' 843)3'* -3('$ )3&4/%3B -1 #39&.3 "D+ 0##(/34)@ A%3 843)3'/3 0# 80.(/3?093' %&)
%3.83B "D+ (' #,.#(..('$ (*) 80.(/('$ #,'/*(0') 9043 3##3/*(O3.1 -1 -3('$ &-.3 *0 43)83/* /,.*,4&.
840%(-(*(0') 0# 9&.3F#39&.3 ('*34&/*(0')@ " 9&>04 &/%(3O393'* (' 9&(')*43&9('$ ?093' (' "D+
() *%3 ('/43&)('$ &//38*&'/3 -1 .0/&. 3.B34) &'B 43.($(0,) .3&B34) 0# ?093' )34O('$ &) 80.(/3
834)0''3.@
A%3 ',9-34 0# 80.(/3?093' &* *%3 *(93 0# ?4(*('$ *%() 43804* 9&Q3) ,8 &-0,* 0'3 834 /3'* 0#
*%3 *0*&. 80.(/3 #04/3@ " )*40'$ '33B () 3f843))3B ?(*%(' "D+ #04 9043 80.(/3?093'@[9840O393'*) (' *349) 0# #39&.3 #4(3'B.1 ('#4&)*4,/*,43 &'B & %($%34 .3O3. 0# &//38*&'/3 0#
#39&.3 80.(/3 ?(*%(' &'B 0,*)(B3 0# "D+ &43 9043 3O(B3'* '0? L(' :;
-
8/11/2019 Women in ANP - A Baseline Assessment
8/73
-
8/11/2019 Women in ANP - A Baseline Assessment
9/73
???@&8840@04$@ i
H%.;"791.'"%
7('/3 *%3 #&.. 0# *%3 A&.(-&' (' :;;< ),-)*&'*(&. )*38) %&O3 -33' *&Q3' *0 ('/43&)3 *%343843)3'*&*(0' 0# ?093' (' &.. #&/3*) 0# .(#3 (' "#$%&'()*&'@ 7*&4*('$ ?(*% &' 0##(/(&. ?093'S)
\,0*& (' *%3 "#$%&' !"#$%& (&)*+ LG0?34 V0,)3 0# *%3 D&*(0'&. "))39-.1N *%3 ',9-34 0# #39&.3
43843)3'*&*(O3) %&) ('/43&)3B *0 :i 834/3'*P /098&43B *0 &40,'B 3/*)@< [' :;;` "#$%&'()*&' ?&) 0'3 0# *%3 #(4)* [).&9(/ /0,'*4(3) *0 4&*(#1 *%3 T0'O3'*(0' 0'
Y.(9('&*(0' 0' ".. H049) 0# E()/4(9('&*(0' "$&(')* M093' LTYE"MN@ : A%3 ^0O34'93'* 0#
"#$%&'()*&' %&) )($'3B *%3 C'(*3B D&*(0') 73/,4(*1 T0,'/(. 23)0.,*(0'
-
8/11/2019 Women in ANP - A Baseline Assessment
10/73
???@&8840@04$@ n
0##(/34) *0 dP;;; -1 J&4/% :;
-
8/11/2019 Women in ANP - A Baseline Assessment
11/73
???@&8840@04$@ 0(' "D+ '0* B,3 *0 &
/099(*93'* *0 )34O3 -,* &) & 93&') 0# 3&4'('$ &' ('/093 &'B )093 0# *%39 B0 '0* 3O3'
,'B34$0 &' 3'*(43 *4&('('$ /0,4)3@
-
8/11/2019 Women in ANP - A Baseline Assessment
12/73
???@&8840@04$@ 3/* L+MJ+N@
J$.+"7"/"*F
A%3 #(3.B 43)3&4/% #04 *%() -&)3.('3 43804* 0' 80.(/3?093' (' "D+ ?&) /0'B,/*3B (' 3&4.1 :;,)*(/3 #04 ?093' &'B 73/,4(*1
73/*04 23#049@ H(3.B 43)3&4/% ?&) /&44(3B 0,* (' W&-,.P U&.&.&-&BP V34&*P J&6&4X3 7%&4(# &'B
W,'B,6 ?%343 +MJ+ () -3('$ (98.393'*3B@ E&*& /0..3/*(0' (' *%3 #(3.B ?&) /&44(3B 0,* *%40,$%
-
8/11/2019 Women in ANP - A Baseline Assessment
13/73
???@&8840@04$@
-
8/11/2019 Women in ANP - A Baseline Assessment
14/73
???@&8840@04$@ 3/* &'B ('#.,3'/3 0'
%0? *%3 840>3/* () (98.393'*3B@
3,15*;"9%7 ." =+'4 3,4$/'%$
"//04B('$ *0 *%3
-
8/11/2019 Women in ANP - A Baseline Assessment
15/73
???@&8840@04$@
-
8/11/2019 Women in ANP - A Baseline Assessment
16/73
???@&8840@04$@ 4'.F&4*F-,(.B('$X&X),)*&('&-.3X.3$(*(9&*3X3##3/*(O3X$%&'()*&'X)3/,4(*1X#04/3 :e &L&;>
-
8/11/2019 Women in ANP - A Baseline Assessment
17/73
???@&8840@04$@
-
8/11/2019 Women in ANP - A Baseline Assessment
18/73
???@&8840@04$@ 04(*1 0# *%3 /&)3) 0# O(0.3'/3 &$&(')* ?093' 439&(') ,'43804*3BP B3)8(*3 &'
('/43&)3 (' *%3 ',9-34 0# 43804*3B /&)3)@ `= ['*34'&*(0'&. &))()*&'/3 *0 "#$%&'()*&' )('/3 :;;,)*(/3 &'B 0*%34 /(O(/ 4($%*)@ A%() -&)3.('3 43804*
?&) /&44(3B 0,* *0 *&Q3 )*0/Q 0# *%3 &//098.()%93'*) *0 B&*3 &'B (B3'*(#1 *%3 439&('('$
/%&..3'$3)@ b3('$ & -&)3.('3P *%3 43)3&4/% $&*%343B &) 9,/% ('#049&*(0' &) 80))(-.3 0' *%3 9&('
/%&..3'$3)P *%3(4 /&,)3)P &'B 8&*%?&1) #04?&4B c &//04B('$ *0 *%3 9&(' )*&Q3%0.B34) c *0 ('#049
#,*,43 840$4&99('$ -1 *%3 +0.(/3 M093' J3'*04)%(8 +40>3/* L+MJ+N@
A0 &BB43)) *%3 /%&..3'$3) #&/3B -1 80.(/3?093' +MJ+ %&) ,'B34*&Q3' #0,4 B(##343'* &/*(O(*(3)R
== 733P #04 3f&98.3P 5f#&9 L:;
-
8/11/2019 Women in ANP - A Baseline Assessment
22/73
???@&8840@04$@ :"";7'%,.'"% 3",;7 PH0>3Q R [+Tb () 43)80')(-.3 #04 /004B('&*('$
('*34'&*(0'&. 3##04*) *0 80.(/3 *4&('('$ &'B 3B,/&*(0'@ [+Tb B03) '0* %&O3 & )83/(#(/ )*4&*3$1 04
8.&' #04 80.(/3?093'P -,* () & 43.3O&'* )*&Q3%0.B34 #04 +MJ+ (' .(&()('$ &'B &BO0/&*('$ #04)*43'$*%3'('$ ?093'S) 40.3 (' *%3 80.(/3@
C9;"N$,% 0"/'1$ J'44'"% PC]0
-
8/11/2019 Women in ANP - A Baseline Assessment
25/73
???@&8840@04$@ :=
W,'B,6P J&6&4P &'B V34&*@ [' 43.&*(0' *0 +MJ+P E1'T048 8.&1) &' (9804*&'* 40.3 ('
/004B('&*(0'P &) *%31 %&O3 840O(B3B *4&('('$) 0' ()),3) )(9(.&4 *0 *%0)3 8.&''3B -1 *%3
T0')04*(,9@
W9#,% :'*+.4 !,.1+ PW:!Q2 V2M () ('O0.O3B (' *%3 ),8804* 0# %,9&' 4($%*) 3'%&'/393'*
&'B (' *%3 /0'*3f* 0# "#$%&'()*&' ?(*% 8&4*(/,.&4 #0/,) 0' ?093'S) 4($%*)@ H04 +MJ+ V2M
/&' 8.&1 & 80*3'*(&..1 80)(*(O3 40.3 *%40,$% &BO0/&/1 &'B 8,-.(/(*1 0' )83/(#(/ ()),3) 0,*.('3B
&) /%&..3'$3) -1 *%3 T0')04*(,9 +&4*'34)@
]%'.$7 -,.'"%4 C%.'.F )"; a$%7$; Cb9,/'.F ,%7 .+$ C#N"6$;#$%. ") !"#$% P]-!"#$%Q2
CDM093' (' "#$%&'()*&' %&O3 *%3 9())(0' *0 3'$&$3 ?093' (' *%3 83&/3 840/3)) &'B &))()*
(' *%3 /43&*(0' 0# ),)*&('&-.3 .(O3.(%00B) #04 ?093'@ ") +MJ+ .('Q) B(43/*.1 *0 *%()
0O34&4/%('$ $0&.P *%343 /0,.B -3 80))(-(.(*(3) #04 #,*,43 ('*34&/*(0' &'B /00834&*(0' -3*?33'
CDM093' &'B *%3 T0')04*(,9@ a$;#,% C#8,44F2 ^349&'1 ?&) ('(*(&..1 &880('*3B &) .3&B '&*(0' (' 43-,(.B('$ *%3 "#$%&'
D&*(0'&. +0.(/3@ 7('/3 :;;e YC+5G *00Q 0O34 80.(/('$ /004B('&*(0'P *4&('('$ &'B 3B,/&*(0'P
3)83/(&..1 .(*34&/1@ [' :;,%,7',% C#8,44F2 T&'&B& %&) /0'*(',0,).1 -33' #,'B('$ & $3'B34 &BO()04 &* J0[@ T&'&B&
%&) &.)0 -33' ('O0.O3B (' *4&('('$ *%3 80.(/3 #04/3 -1 )3'B('$ =d T&'&B(&' H04/3) *4&('34) *0
3'%&'/3 *%3 /&8&/(*1 0# *%3 "#$%&' D&*(0'&. +0.(/3@ Z9.1+ C#8,44F2 () & B0'04 '&*(0' 0# CDE+FG5AH" &'B %&) #('&'/(&..1 ),8804*3B & O&4(3*1 0#
('(*(&*(O3) #04 80.(/3?093' ),/% &) .(*34&/1 &'B *%3 ,)3 0# /3.. 8%0'3)@ A%3 E,*/% Y9-&))1
&.)0 #,'B)
-
8/11/2019 Women in ANP - A Baseline Assessment
26/73
???@&8840@04$@ :d
D&*(0'&. +0.(/3 (' 43/0$'(*(0' &'B 843O3'*(0' 0# $3'B34 X-&)3B O(0.3'/3@ CDH+" %&)
B3O3.083B & )83/(#(/ /0,4)3 &'B & /09843%3')(O3 J&',&. #04 +0.(/3 "/*(0' &$&(')* ^3'B34
b&)3B a(0.3'/3P &8840O3B -1 J0[ (' :;"9%1'/4 R *%343 &43 +0.(/3 M093'S) T0,'/(.) (' W&-,.P b&9(1&'P V34&*P
J&6&4X3 7%&4(# &'B W,'B,6@ A?0 /0,'/(.) Lb&9(1&' &'B J&6&4X3 7%&4(#N 43/3(O3 /&8&/(*1-,(.B('$ ),8804* -1 "#$%&' M093'S) D3*?04Q L"MDN &'B 0'3 /0,'/(. LW&-,.N %&) 43/3(O3B
93'*04('$ ),8804* #409 YC+5G@ H04 +MJ+ *%3)3 /0,'/(.) /&' )34O3 8.&*#049) *0 84090*3
*%3 840>3/* &'B $&(' ('#049&*(0' &-0,* ()),3) *%&* /0'/34' 80.(/3?093'@
J'%'4.;F ") H%.$;'"; PJ"HQ R () *%3 43)80')(-.3 9('()*41 #04 "D+ &'B %&) &' ('*3$4&*3B ^3'B34
&'B V,9&' 2($%*) C'(*@ J0[ () /099(**3B *0 ('/43&)3 *%3 ',9-34 0# 80.(/3?093' *0 dP;;;
-1 J&4/%@ " /0'#343'/3 () 8.&''3B (' :;"##'44'"% P(HW:>Q R A%3 "[V2T 43804*) 0'
-43&/%3) &$&(')* %,9&' 4($%*) (' "#$%&'()*&'@ A%31 %&O3 43$,.&4 23804*) 0' a(0.3'/3 "$&(')*
-
8/11/2019 Women in ANP - A Baseline Assessment
27/73
???@&8840@04$@ :e
M093' &'B &' 59-,B)9&' 43)80')(-.3 #04 %,9&' 4($%*) (' J0[@ "[V2T %&) -33' ('O0.O3B ('
*4&('('$ 0# 80.(/3?093' (' '04*%34' 840O('/3) &'B () & 80*3'*(&. 8&4*'34 #04 +MJ+ 0,*43&/%@
T,#'/F :$4N"%4$ ]%'.4 PT:]Q R H&9(.1 23)80')3 C'(*) &43 & 8&4* 0# J0[s) T4(9('&. ['O3)*($&*(0'
E38&4*93'* 43)80')(-.3 #04 B3&.('$ ?(*% B093)*(/ O(0.3'/3 ()),3)@ H2C) &43 ),880)3B *0 -3
)*#3B -1 ?093' ?(*% *%3 9&(' *&)Q 0# B3&.('$ ?(*% /&)3) 0# O(0.3'/3 &$&(')* ?093'@ H2C)S
834)0''3. )%0,.B *%,) -3/093 B(43/*.1 ('O0.O3B ?(*% +MJ+@
a$;#,% 0"/'1$ 0;"O$1. =$,# Pa00=Q R () 43)80')(-.3 #04 *4&('('$ %($%X4&'Q('$ 80.(/3 0##(/(&.)@
H04 +MJ+ /00834&*(0' ?(*% ^++A ?0,.B -3 ,)3#,. (' $&('('$ &//3)) *0 %($% 4&'Q('$ 80.(/3
0##(/(&.) &'B -,(.B('$ 0' &//098.()%93'*) &.43&B1 9&B3@
()*+,% !"#$%d4 -$.6";5 P(!-Q R /0'B,/*) /&8&/(*1 -,(.B('$ #04 80.(/3?093'S) /0,'/(.) ('
J&6&4X3 7%&4(# &'B b&9(1&'@ +0.(/3?093' /0,'/(.) &43 & 80*3'*(&..1 ,)3#,. )0,4/3 0#
('#049&*(0' #04 +MJ+ ?%(.3 /.0)34 /00834&*(0' -3*?33' +MJ+ &'B "MD () .(Q3.1 *0)*43'$*%3' +MJ+S) .3$(*(9&/1 &'B 3##3/*(O3'3))@
J"H >"%49/.,.'@$ >"9%1'/ R () &' &BO()041 -0B1 *0 J0[ 0# /(O(. )0/(3*1 04$&'(6&*(0')@ +MJ+
/0,.B )33Q /.0)34 /00834&*(0' ?(*% *%() T0,'/(. *0 )*43'$*%3' 43.&*(0') -3*?33' ?093'X
/3'*343B /(O(. )0/(3*1 04$&'(6&*(0') &'B J0[@
_';*,4 ,%7 E+9;,4 R *4&B(*(0'&. .0/&. -0B(3) #(49.1 39-3BB3B (' *%3 )0/(&. )*4,/*,43 ?(*% &
),-)*&'*(&. ('#.,3'/3 0' 43)0.O('$ /0'#.(/*) &'B /%&'$('$ 834/38*(0')@ U(4$&) &'B 7%,4&) /0,.B
8.&1 /4,/(&. 40.3) (' &?&43'3)) 4&()('$ &'B &?&43'3)) /%&'$('$ ?(*%(' *%3(4 /099,'(*(3) &'B
&) ),/% /0,.B -3 ,)3B *0 84090*3 +MJ+@ [* 9,)* -3 '0*3B *%&* (' )*&Q3%0.B34 9&88('$ *%3)3
*4&B(*(0'&. )*4,/*,43) 0# $0O34'&'/3 &43 B(##(/,.* *0 ('/.,B3 (' *%3 9&*4(f &) *%3(4 ('*343)* ('P
&'B ),8804* #04 +MJ+ O&4(3) #409 .0/&*(0' *0 .0/&*(0'@
J"4b9$4 R &43 0'3 0# *%3 90)* ('#.,3'*(&. #049) 0# *4&B(*(0'&. (')*(*,*(0')@ ['(*(&*(O3) )%0,.B
*%,) -3 *&Q3' *0 ?04Q 9043 /.0)3.1 ?(*% 43.($(0,) .3&B34) (' O&4(0,) 90)\,3) *0 4&()3
&?&43'3)) &'B /&441 0,* &BO0/&/1 &/*(O(*(3)@ 7(9(.&4 *0 )%,4&) &'B >(4$&)P 90)\,3) O&41 ('
*%3(4 ('#.,3'/3 &'B ('*343)* #409 .0/&*(0' *0 .0/&*(0'@
-
8/11/2019 Women in ANP - A Baseline Assessment
28/73
???@&8840@04$@ :g
T'*9;$ R2 H%)/9$%1$^H%.$;$4. J,.;'D
H%.$;$4.
W'*+ ?"6
CDE+FG5AH"DAJX"FT7ATX"J0[
"++25"M7ETM"M
J3B(/&UH"5
YC+5GCD"J"
+0.(/3?093' T0,'/(.)H2C)
[+Tb L('/@ YCN^.0-&. 2($%*)
CDH+"J0[ T0'),.*&*(O3 T0,'/(.
"MDT&'&B(&' Y9-&))1
J0M" H %
) / 9 $ % 1 $
W'*+
?"6
E[U77+^++A"[V2T
E,*/% Y9-&))1^349&' Y9-&))1
J0V2"J0[T
J0UC7P b4(*()%P D04?3$(&'P
7?())P [*&.(&'P H('()%PE&'()%P T63/%P &'B
U&8&'3)3 Y9-&))(3)CDM093'
V2M
S$F T'%7'%*4 );"# T'@$ 0;"@'%1$4
S9%79U
W,'B,6 ?&) O()(*3B -3*?33' U&',&41 := &'B H3-4,&41 =P :;
-
8/11/2019 Women in ANP - A Baseline Assessment
29/73
???@&8840@04$@ :i
.&/Q 0# \,&.(#(3B #39&.3 /&'B(B&*3)@ A%3 *%433 #39&.3 0##(/34) (' W,'B,6 ?04Q (' *%3 43/4,(*93'*
B38&4*93'* &'B &43 /%&4$3B ?(*% 43/4,(*('$ #39&.3 '0'X/099())(0'3B 0##(/34)@ "* *%3 *(93 0#
*%3 #(3.B O()(*P '0 ?09&' %&B -33' #(43B (' *%3 )0.&4 13&4
Q S$-+#$ 6"#&2$ F$2)9&/-$./ W00&2$) B V9.;9X
J0)* 0# *%3 80.(/3?093' ('*34O(3?3B (' W,'B,6 )&(B *%31 ?343 '0* /0'/34'3B &-0,* *%3 :;
-
8/11/2019 Women in ANP - A Baseline Assessment
30/73
???@&8840@04$@ :n
A%3 %3&B 0# H2C (' W,'B,6 () 9&.3@ A%343 ?343 #04*1 )(f /&)3) 43$()*343B (' :;
-
8/11/2019 Women in ANP - A Baseline Assessment
31/73
???@&8840@04$@ `;
^40,8) ?&) )33' &) & *&)Q 8&4*(/,.&4 *0 93'@ 23.&*(0') -3*?33' 9&.3 &'B #39&.3 80.(/3
834)0''3. ?343 B3)/4(-3B &) 43)83/*#,.@ d:
0;"4N$1.4
b0*% 9&.3 &'B #39&.3 80.(/3 &43 ),8804*(O3 0# ('/43&)('$ *%3 ',9-34 0# #39&.3 80.(/3 0##(/34) ('
*%3 A&)%Q33.P 840O(B3B *%&* *%31 &43 '0* 904&..1 /044,8* &'B ?(..('$ *0 *&Q3 0' 80.(/('$ *&)Q)@
A%3 9&(' 43&)0' #04 *%() -40&B ),8804* #04 ?093' (' "D+ &883&4) *0 -3 *%3(4 80)(*(O3
/0'*4(-,*(0' (' *%3 #049 0# %0,)3 )3&4/%3)P B3&.('$ ?(*% O(0.3'/3 &$&(')* ?093' /&)3) &'B
B()/0O34('$ ('),4$3'*) %(B('$ ,'B34 #39&.3 /.0*%('$@ d` [' &BB(*(0'P *%3 ('*34'&. ),8804* #04
?093' ?04Q('$ (' "D+ ('/.,B3B *%3 T099&'B34 43$,.&4.1 4&()('$ &?&43'3)) &'B &BO0/&*('$
&884084(&*3 &'B 43)83/*#,. *43&*93'* 0# #39&.3 #3..0? ?04Q34)@d=
") & 93&') *0 /0')0.(B&*3 *%3 80)(*(O3 834/38*(0' 0# ?093' ?(*%(' *%3 80.(/3 &'B )843&B (* *0
*%3 ?(B34 )0/(3*1P "D+ %&) ('*40B,/3B & $3'34&. -&/Q$40,'B /%3/Q *0 ('O3)*($&*3 *%3 #&9(.(&.
&'B 0*%34 -&/Q$40,'B 0# #39&.3 &88.(/&'*)@ A%3)3 /%3/Q) &43 ?3.. 43/3(O3B -1 -0*% 93' &'B
?093' &) & 93&') *0 3'),43 ?093' 0# $00B 438,*&*(0' &43 43/4,(*3B *0 *%3 80.(/3@ dd
[' W,'B,6 80.(/393' &'B 80.(/3?093' 43804*3B *%&* *%31 ?343 *4&('3B (' ,)('$ & $,'P &88.1('$
%&'B/,##)P )3.#XB3#3')3P /4(9('&. ('O3)*($&*(0'P %0,)3 &'B -0B1 )3&4/% &'B B39('('$@ A%3
*4&('('$ &'B ),8804* ('#4&)*4,/*,43 #04 840#3))(0'&. *4&('('$ (' W,'B,6 &43 840O(B3B *%40,$%
^++AP +0.(/3 A4&('('$ T3'*43 &'B "#$%&' +0.(/3 "/&B391@ A4&('('$ 0' %,9&' 4($%*)P ?093'S)
4($%*)P 43.&*(0') ?(*% B3*&('33) &'B (9804*&'* .3$&. B0/,93'*)P ),/% &) *%3 "#$%&' T0')*(*,*(0'
&'B Ya"M .&? &43 840O(B3B #04 -1 "#$%&'()*&' ['B383'B3'* V,9&' 2($%*) T099())(0' L"[V2TN
&'B & ',9-34 0# /(O(. )0/(3*1 04$&'(6&*(0')P ),/% &) U,)*(/3 #04 ".. 54$&'(6&*(0' LUH"5N@ de
A%3 Q'0?.3B$3 0# ('*34'&*(0'&. /0'O3'*(0') 0' ?093'S) 4($%*) ?&) .(9(*3B B3)8(*3 *%3 #&/* *%&*
*%343 ?&) &?&43'3)) 0# *%3 (9804*&'/3 0# %,9&' 4($%*) &'B 80.(/3 F /099,'(*1 /00834&*(0'@
A%3 T0')*(*,*(0' &'B *%3 Ya"M .&? L-,* '0* D"+M"N ?343 (B3'*(#(3B &) /4,/(&. &'B )*4&*3$(/
d: WCD`d` WCD
-
8/11/2019 Women in ANP - A Baseline Assessment
32/73
???@&8840@04$@ `+,//$%*$4
M%(.)* *%3 '33B #04 /099,'(*1 &'B 80.(/3 /00834&*(0' () 43/0$'(63B &* & #049&. .3O3. &'B ?(*%('*%3 80.(/3P ?04Q('$ #04 *%3 80.(/3 439&(') & /0'*40O34)(&. ()),3 &90'$)* *%3 $3'34&. 8,-.(/P
8&4*(/,.&4.1 (' 43.&*(0' *0 ?093' ?04Q('$ #04 *%3 80.(/3@ di A?0 80.(/3?093' 43804*3B *%&* *34
43*,4'('$ #409 & #&9(.1 #3)*(O(*1 0' *%3(4 ?&1 -&/Q %093 *%31 #0,'B & )*4&'$34 ?&(*('$ (' #40'*
0# *%3(4 %0,)3 ?(*% &' &88&43'* ('*3'* 0# ('*(9(B&*(0'@ A%3 ?093' (' *,4' &BB43))3B %(9
8,-.(/.1P B39&'B('$ *0 Q'0? &,B(-.1 &'B .0,B.1 ?%&* %3 ?&) B0('$ *%343P *34 ?%(/% *%3
)*4&'$34 *,4'3B &-4,8*.1 &'B 4&' &?&1@ A%343 %&O3 &.)0 -33' 0//&)(0') 0# 80.(/3?093' -3('$
*&,'*3B -1 )093 )%08Q33834) ?%0 9&Q3 ),$$3)*(O3 439&4Q) 3\,&*('$ -3('$ & 80.(/3?09&' *0
-3('$ & 840)*(*,*3@dn
".*%0,$% 90)* 0# *%3 ?093' &43 3'$&$3B (' 80.(/('$ *&)Q)P 80.(/3?093' &43 *%3 ),->3/*) 0# &
',9-34 0# '3$&*(O3 834/38*(0') -1 -0*% 80.(/393' &'B 80.(/3?093'@ +0.(/3?093' ?343 )&(B
*0 -3 0#*3' .&*3 #04 ?04QP &-)3'* #04 9&'1 B&1) 0' & 43$,.&4 -&)()P &'B 0'.1 *,4'('$ ,8 *0 /0..3/*
*%3(4 )&.&4(3)@ 7093 80.(/393' .00Q B0?' 0' *%3(4 #39&.3 /0..3&$,3) &) ,'B34 \,&.(#(3B &'B .3))
/099(**3B@ V0?3O34P ?%3' *%3)3 &..3$&*(0') ?343 3f8.043B #,4*%34 ?(*% *%3 /098.&('&'*)P *%31
&B9(**3B *%&* .&*3'3)) #04 ?04QP #04 3f&98.3P ?&) -3/&,)3 ?093' %&B &BB(*(0'&. B093)*(/
B,*(3) &) 90*%34) &'B ?(O3)@e;
dg WCDidi WCDgdn WCD:P WCD`e; WCD
-
8/11/2019 Women in ANP - A Baseline Assessment
33/73
???@&8840@04$@ `:
Yf/38* #04 *%3 %($%34 .3O3. 0##(/34) *%3 )&'(*&41 840O()(0') 439&(' 8004 #04 *%3 .0?34 4&'Q('$
834)0''3.@ A%343 &43 '0 /%(.B/&43 #&/(.(*(3)P '0 )38&4&*3 *0(.3*) #04 93' &'B ?093'P '0 )38&4&*3
3&*('$ 4009 &'B '0 #39&.3 0'.1 /%&'$('$ 4009)@ M%(.3 8004 &'B ('&B3\,&*3 #&/(.(*(3) &43 \,(*3
/0990' 840-.39) *%40,$%0,* "#$%&'()*&'P *%3 .&/Q 0# /%(.B/&43 #&/(.(*(3) %&) & B(43/* '3$&*(O3
(98&/* 0' 80.(/3?093'S) &-(.(*1 *0 #,.#(.. *%3(4 >0-)@ e< "**398*) *0 (9840O3 -&)(/ &93'(*(3) %&B
-33' ,'),//3))#,. &'B )093 ('*34O(3?33) /098.&('3B *%&* W&-,. ?&) ,'43)80')(O3 *0 *%3(4
B39&'B) &'B *%&* *%3)3 -&)(/ '33B) ?343 '0* -3('$ 43/04B3B )1)*39&*(/&..1 B,4('$ 90'(*04('$
O()(*) -1 834)0''3. #409 J0[ (' W&-,.@
".. 80.(/393' ?343 )&(B *0 43/3(O3 0##(/(&. *4&')804* *0 ?04Q -,* '0* &.. 80.(/3?093'@ 7093
80.(/3?093' &43 43.,/*&'* *0 9&Q3 ,)3 0# *%3 0##(/(&. 80.(/3 *4&')804*&*(0' &'B 843#34 84(O&*3
*4&')804*&*(0'P B3393B .3)) 0# & *&4$3* #04 "493B 5880)(*(0') ^40,8)@e:
[' &BB(*(0'P )093 0#*%3 ?093' 3f843))3B 43)34O&*(0') &-0,* -3('$ &))0/(&*3B ?(*% 80.(/3 O3%(/.3) ?%0)3 B4(O34)
&/*3B B()43)83/*#,..1 *0?&4B /(O(.(&' B4(O34) &'B /0')()*3'*.1 B()0-313B *4#(/ 4,.3)P 43('#04/('$
*%3 '3$&*(O3 (9&$3 0# *%3 80.(/3 (' *%3 313) 0# *%3 8,-.(/@
:$1"##$%7,.'"%4
"//04B('$ *0 80.(/393' &'B 80.(/3?093' &' ('/43&)3 (' #39&.3 80)(*(0') (' *%3 A&)%Q33. ?0,.B
(9840O3 *%3 \,&.(*1 0# 80.(/3 ?04Q (' "D+@ Y98%&)() ?&) 8.&/3B 0' ('/43&)('$ %($%X4&'Q('$
80)(*(0') #04 ?093'@ [' &BB(*(0' *0 *%3 3f()*('$ &43&) ?%343 80.(/3?093' &43 &.43&B1
398.013BP ?093' /0,.B 8.&1 & 9043 /3'*4&. 40.3 (' *%3 840*3/*(0' 0# $(4.)S )/%00.) (' *%3
840O('/3)P %3&.*%/&43 B38&4*93'*)P ('*3..($3'/3 ?04Q &'B *&4$3*3B 43/4,(*93'* *0 &**4&/*
3B,/&*3B ?093' *0 >0(' "D+@ e`
" )3/0'BP O341 8409('3'* 80('* ?&) *%3 (9&$3 *%&* /,443'*.1 3f()*) &-0,* ?093' ?04Q('$ ('
"D+@ J3B(& /&98&($') ?343 ),$$3)*3B *0 ,'B34.('3 *%3 (9804*&'* 40.3 0# ?093' (' *%3 80.(/3
&.0'$ ?(*% & 43/4,(*93'* /&98&($' *&4$3*('$ *%3 $4&B,&*('$ /.&))3) 0# %($% )/%00.)@ [' &.. ),/%
3##04*)P 43/4,(*93'* 0# ?093' ?0,.B '33B *0 -3 ),->3/* *0 &' ('O3)*($&*(0' 0# #&9(.1
-&/Q$40,'B &'B /00834&*(0' ?(*% .0/&. 3.B34)@ A0 3'),43 *%&* *%3 (9&$3 0# ?093' (' 80.(/3
e< A%3 )&'(*&41 #&/(.(*(3) &43 8004 &'B ('&B3\,&*3 #04 9&.3) &'B #39&.3)@ " ',9-34 0# 80.(/393' &.)0/098.&('3B &-0,* *%3 .&/Q 0# #&/(.(*(3) ('/.,B('$ )&'(*&41 840O()(0') &'B .3&Q('$ 400#)@e: WCDie` WCD
-
8/11/2019 Women in ANP - A Baseline Assessment
34/73
???@&8840@04$@ ``
B03) '0* ),##34P (* ?&) ),$$3)*3B *%&* 904&..1 /044,8* ?093' (' 80.(/3 )%0,.B -3 #(43B &'B
-&''3B #409 ?04Q('$ ?(*% "D+@ e=
T099,'(/&*(0' -3*?33' *%3 /3'*4&. &B9('()*4&*(0' (' W&-,. &'B *%3 840O('/3) )%0,.B -3
('/43&)3B &'B 43)80')(O3'3)) 0# *%3 /3'*4&. &B9('()*4&*(0' *0 *%3 ',9340,) &'B /%&..3'$('$
'33B) (' *%3 840O('/3)P ),/% &) &B3\,&*3 ('#4&)*4,/*,43P )%0,.B -3 ('/43&)3B@ +4090*(0')
('(*(&*3B &* *%3 840O('/(&. .3O3. )%0,.B -3 840/3))3B 9043 84098*.1P &) & 93&') *0 /43&*3
('/3'*(O3) #04 ?093' *0 >0(' *%3 80.(/3@ ed
e= WCDged WCD
-
8/11/2019 Women in ANP - A Baseline Assessment
35/73
???@&8840@04$@ `=
S,89/
A%(4*33' ('*34O(3?) ?343 %3.B (' W&-,. -3*?33' U&',&41 i &'B U&',&41 0('('$ *%3 80.(/3 &883&4) *0 -3 3/0'09(/P *%343 &43 ('B(/&*(0') *%&*
)093 ?093' >0(' "D+ 0,* 0# 84(B3 &'B & /099(*93'* *0 )34O3 *%3 /099,'(*1@ H04 3f&98.3P
0'3 80.(/3?09&' )&(B *%&* `; 13&4) &$0 )%3 -3/&93 & 80.(/3 0##(/34 0,* 0# 84(B3@ A0B&1 )%3
?04Q) 0' $3'B34 &'B %,9&' 4($%*) ()),3) (' W&-,.@ eg
J0)* 0# *%3 80.(/3?093' ('*34O(3?3B (' W&-,. &43 '0* /0'/34'3B &-0,* *%3 :;
-
8/11/2019 Women in ANP - A Baseline Assessment
36/73
???@&8840@04$@ `d
,'),//3))#,.P /&)3) &43 43#3443B *0 *%3 +40)3/,*04) 5##(/3 &'B *%3 0##(/(&. /0,4* )1)*39@ [#
43\,(43B #04 840*3/*(0' 8,480)3)P ?093' &43 43#3443B *0 )%3.*34) 04 B3*3'*(0' /3'*34)@ en
!"#$% '% (-02 09;N"4$c 0$;1$N.'"% ,%7 a$%7$;$7 Z'))$;$%1$4
A%3 9&(' *&)Q 0# "D+ %&) -33' *%3 840O()(0' 0# -&)(/ )3/,4(*1 &'B /0,'*34('$ *34404()9@ ^00B
43.&*(0') -3*?33' *%3 80.(/3 &'B *%3 /099,'(*1 %&O3 -33' ('/43&)('$.1 )*43))3B &) /4,/(&. #04
80.(/('$ ?04Q *0 -3 3##3/*(O3 &'B ),)*&('&-.3@ A%343 () ('),##(/(3'* ,'B34)*&'B('$ 0#
80.(/3F/099,'(*1 43.&*(0')P %0?3O34@ A%3 /0'/38* () )093*(93) ('*34843*3B &) *%3 840*3/*(0'
0# *%3 /099,'(*1 (' /00834&*(0' ?(*% .0/&. 3.B34)@ 7093 0# *%3 ('*34O(3?33) *%0,$%* 0#
/099,'(*1 80.(/('$ &) *%3 80.(/3 -3('$ 0-.($&*3B *0 &**3'B *%3 90)\,3 &* H4(B&1 84&134)@ g;
M093' &43 )33' &) & /4,/(&. &))3* #04 *%3 80.(/3 (' B0('$ -0B1 )3&4/% 0# ?093' &'B /0'B,/*('$/4(9('&. ('O3)*($&*(0' ?%3' ?093' &43 ('O0.O3BP &) O(/*(9) 04 &) 83483*4&*04)@ g< A%3 90)*
/0990' *&)Q) #04 80.(/3?093' (' W&-,. ?343 $(O3' &) %0,)3 )3&4/%3) &'B 0##(/3 B,*(3)@ A%343
?343 $3'34&. B(##343'/3) -3*?33' 93' &'B ?093' /0'/34'('$ #(43&49) &) ?093' ?343 )&(B *0
0'.1 -3 &..0?3B )9&..34 %&'B$,')@ 7(9(.&4 *0 W,'B,6P #40'*.('3 #($%*('$ ?&) )33'P -1 *%3 93'
&'B )093 0# *%3 ?093'P &) 0'.1 93'S) ?04Q@ ".)0 )(9(.&4 *0 W,'B,6P ?093' B0 '0* ?04Q
'($%*)%(#*) 43$,.&4.1 -,* &43 /&..3B 0' (' 3934$3'/(3)@
23.&*(0') -3*?33' 80.(/3?093' &'B 80.(/393' ?343 )&(B *0 -3 )&*()#&/*041@ V0?3O34P )093 0#
*%3 93' )*&*3B *%&* *%3(4 #39&.3 /0..3&$,3) ?343 904&..1 /044,8* &'B ,'B34X\,&.(#(3B #04 %($%34
80)(*(0')@ ".)0P 0'3 ?09&' /098.&('3B &-0,* B()43)83/*#,. *43&*93'* -1 9&.3 /0..3&$,3)R
: 4+@$ *""; )$#+/&".% E&/4 A"#&2$E"-$.C L9/ : 4+@$ A)"L#$- E&/4 -8 L"%% ]E4" &% + -+.^> : 4+@$
." +22$%% /" /)+.%A")/+/&".C E4$. : *$/ A&2O$; 9A /" 2"-$ /" E")O ") )$/9). L+2O 4"-$ ]%"-$
2"##$+*9$% %+8^ /4+/ : 4+@$ %$_9+# )$#+/&".% E&/4 /4$ ;)&@$)% +.; )$A")/ -$ /" -8 %9A$)&")%> : 4+@$
+#%" L$$. &.%9#/$; L8 -8 -+#$ %9A$)&")% &. A9L#&2>
Q S$-+#$ &./$)@&$E$$ B V+L9#
en W"b0(' *%3 80.(/3
&'B 9&Q3 ?093' ?04Q('$ (' *%3 80.(/3 9043 43?&4B('$@ ") (' W,'B,6 *%3 #39&.3 ('*34O(3?33)
&.)0 )*43))3B *%3 (9804*&'/3 0# %&O('$ &B3\,&*3 ?04Q('$ #&/(.(*(3)P ('/.,B('$ &//3)) *0 0##(/(&.
*4&')804*&*(0'@gi
gd W"bgP W"b=ge W"b
-
8/11/2019 Women in ANP - A Baseline Assessment
39/73
???@&8840@04$@ `i
-,%*,;+,;
H0,4 B()*4(/*) ?343 O()(*3B (' D&'$&4%&4 -3*?33' E3/39-34 :=P :;
-
8/11/2019 Women in ANP - A Baseline Assessment
40/73
???@&8840@04$@ `n
*%3 80.(/3?093' )*&*3B *%&* *%31 '33B3B #,4*%34 *4&('('$ (' .(*34&/1P *%3 Ya"M .&? &'B
B3*3'*(0' .&?)@ i;
J0)* #39&.3 80.(/3 (' D&'$&4%&4 ?04Q &) -0B1 )3&4/%34) (' B(##343'* B38&4*93'*) ),/% &) *%3
T4(9('&. ['O3)*($&*(0' E38&4*93'* &'B T0,'*34'&4/0*(/)@ M093' &43 &.)0 ('O0.O3B ('
43/4,(*93'* &'B 0O34)33('$ ?093'S) )%3.*34) &'B /0,4* B3*3'*(0' /3'*34)@ H,4*%34 B38&4*93'*)
(B3'*(#(3B &) ),(*&-.3 #04 ?093' ?343 ['*3..($3'/3P H&9(.1 23)80')3 &'B ^3'B34 C'(*) &'B *%3
8&))804* B38&4*93'*@ ^,&4B('$ #39&.3 84()0'34) &'B ,'B34*&Q('$ ('*3440$&*(0') ?343 &.)0
$(O3' &) 3f&98.3) 0# &43&) ?%343 ?093' /0,.B 8.&1 & 9043 /3'*4&. 40.3@ i< T,443'*.1P ?093' B0
'0* ?04Q '($%*)%(#*) (' D&'$&4%&4P -,* &43 0' /&.. #04 3934$3'/1 /&)3)@
H39&.3 80.(/3 #33. $3'34&..1 ?3.. *43&*3B -1 *%3(4 9&.3 /0..3&$,3)@ 23.&*(0') &43 )&(B *0 -343)83/*#,. &'B 90)* 0# *%3 ?093' )&(B *%31 %&B 9043 /0'*&/* ?(*% *%3 80.(/393' *%&' ?(*%
/0990' #39&.3 /0..3&$,3)P &) *%343 &43 9&'1 9043 93' *%&' ?093' (' *%3(4 (993B(&*3
?04Q('$ 3'O(40'93'*@ i: T0'*4&41 *0 *%3 #39&.3 80.(/3P 9&.3 80.(/3 ?343 '0* &) 80)(*(O3 &-0,*
*%3(4 #39&.3 /0..3&$,3) &'B B3)/4(-3B *%39 &) (..(*34&*3 &'B ,'B34 \,&.(#(3B@ A%3 O341 .0? .3O3.
0# .(*34&/1 L*%433 0# *%3 `d ?093' /&' 43&B -,* /&''0* ?4(*3N ,'B349('3) *%3 ?093'S) &-(.(*1
*0 $&(' 43)83/* &'B 43/0$'(*(0' 04 #,..1 -3'3#(* #409 *%3 O&4(0,) #049) 0# *4&('('$ -3('$ 9&B3
&O&(.&-.3 *0 *%39@i` H04 3f&98.3R
: O."EC 4+@&.* A"#&2$E"-$. &. 356 &% %&*.&0&2+./ 0") *""; A"#&2$ A$)0")-+.2$ +.; /" -$$/
A"#&2&.* *"+#%> T9/ +#-"%/ +## /4$ A"#&2$E"-$. +)$ #&/$)+/$ +.; 2+.."/ 09##8 A$)0")- /4$&) ;9/&$%>
Q M+#$ )$2)9&/-$./ "00&2$) B 5+.*+)4+)
+0.(/393' /098.&('3B *%&* *%3(4 #39&.3 /0..3&$,3) B0 '0* %&O3 *%3 )&93 ?04Q 3*%(/) &) 93'@
23804*3B.1P ?093' *3'B3B *0 &44(O3 .&*3 #04 ?04QP .3&O3 3&4.1P 04 '0* *,4' ,8 &* &..@ 7093 93'
&**4(-,*3B *%() Q('B 0# -3%&O(04 *0 *%3 #&/* *%&* ?093' %&B -33' ?04Q('$ 0'.1 43/3'*.1 &'B
%3'/3 '0* 13* &/\,(43B & h840#3))(0'&. 9('B)3*S@ M093' 43)80'B3B *0 *%3)3 &..3$&*(0') -1
i; D"D
-
8/11/2019 Women in ANP - A Baseline Assessment
41/73
???@&8840@04$@ =;
)*&*('$ *%&* *%31 %&B *0 *&Q3 /&43 0# B093)*(/ B,*(3) ),/% &) *&Q('$ *%3(4 /%(.B43' *0 )/%00. &'B
8438&4('$ 93&.) &* %093 (' &BB(*(0' *0 B0('$ *%3(4 >0- &* *%3 80.(/3@
0;"4N$1.4
"* *%3 *(93 0# *%3 O()(* (' .&*3 E3/39-34 :;
-
8/11/2019 Women in ANP - A Baseline Assessment
42/73
???@&8840@04$@ =+,//$%*$4
A%343 () & $3'34&. .&/Q 0# #&/(.(*(3) #04 ?093'P %($% .3O3.) 0# (..(*34&/1P ('&B3\,&*3 04 '0
,'(#049)P '0 B3B(/&*3B *4&')804*&*(0'P )9&.. -0B1 )3&4/% 4009)P .&/Q 0# 3\,(893'* &'B
#,4'(*,43 &'B .&/Q 0# &B3\,&*3 )&'(*&41 #&/(.(*(3) &'B /%&'$('$ 4009)@ in [' 90)* ?&1) *%3
/0')*4&('*) #04 80.(/3?093' (' D&'$&4%&4 &43 9043 840'0,'/3B *%&' (' W,'B,6 &'B W&-,.@ H04
3f&98.3P ?093' B0 '0* 0'.1 /098.&(' &-0,* *%3 )(63 0# )3&4/%('$ 4009)F-0f3) -,* *%3 #&/*
*%&* *%343 &43 '0 B3)($'&*3B )3&4/%('$ &43&) &* &..@ "* *(93) ?093' %&O3 *0 $0 (')(B3 & *3'* #04
)3&4/%('$P ?%(/% /&' -3 O341 /0.B (' ?('*34@ [# ?093' ?&'* *0 3&* )38&4&*3.1P *%31 0#*3' 3'B ,8
3&*('$ (' *%3 Q(*/%3'@n; "BB(*(0'&..1P ?093' B0 '0* ?&'* *0 ,)3 8,-.(/ *4&')804*&*(0'P &) *%31
&43 &(B 0# %&4&))93'* 0' *%3(4 ?&1 *0 &'B #409 ?04Q@
" B3*34(04&*('$ )3/,4(*1 )(*,&*(0' ?0,.B B3/43&)3 *%3 840-&-(.(*1 0# ?093' 43&/%('$ *%3(4?04Q8.&/3 ?(*%0,* 4()Q) ('O0.O3B@ 7093 80.(/3?093' &43 ?044(3B &-0,* *%3 )0/(&. )*($9&
&))0/(&*3B ?(*% ?04Q('$ #04 "D+@ J0)* 0# *%3 ?093' ?0,.B 0'.1 *3.. *%3(4 /.0)3 43.&*(O3) *%&*
*%31 ?343 ?04Q('$ #04 *%3 80.(/3 &'B 843#34 '0* *0 ?3&4 *%3(4 ,'(#049 (' 8,-.(/@ +0.(/3?093'
083'.1 &B9(**3B *0 -3('$ &(B 0# Q(B'&88('$)P &/(B &**&/Q) &'B 8%1)(/&. &'B O34-&. &))&,.*@n<
H04 3f&98.3R
: +- %2+)$; /" %4"E -8%$#0 9.&0")-$; &. A9L#&2 +% + -$-L$) "0 356> :/ E# /+O$ %"-$ /&-$ 0") A$"A#$ /" +22$A/ E"-$. &. /4$ A"#&2$ L9/ : 4"A$E$ E# *" 0")E+); /" +24&$@$ /4&%>
Q S$-+#$ 5".Q2"--&%%&".$; "00&2$) B 5+.*+)4+)
"'0*%34 80.(/3?09&' 43804*3B *%&* & )*4&'$34 8%1)(/&..1 &))&,.*3B %34 0' %34 ?&1 %093 #409
?04Q &'B &.*%0,$% %34 '3($%-04) 43)/,3B %34P )%3 *00Q )34(0,) ('>,4(3) (' %34 #&/3@n: A%3)3
/%&..3'$3) (' /09-('&*(0' ?(*% *%3 .&/Q 0# &?&43'3)) &'B Q'0?.3B$3 0# *%3 $3'34&. 8,-.(/
&-0,* 80.(/('$ &) & ,)3#,. 8,-.(/ )34O(/3 &43 *%3 9&(' 43&)0') #04 3B,/&*3B ?093' '0* -3('$
('*343)*3B (' ?04Q('$ #04 *%3 80.(/3@ n`
in D"D:n; D"Dgn< D"D:P D"Ddn: D"D`n` D"D`P D"Dd
-
8/11/2019 Women in ANP - A Baseline Assessment
43/73
???@&8840@04$@ =:
A%3 /,.*,4&. 43)*4(/*(0') ?093' #&/3 (' D&'$&4%&4 &43 9043 )3O343 *%&' (' 0*%34 840O('/3)@
G0/&. 43.($(0,) .3&B34) &'B #3..0? 80.(/393' )*(.. )339 O341 43.,/*&'* *0 &//38* ?093' ?04Q('$
(' *%3 80.(/3@n= "' &BB(*(0'&. /%&..3'$3 (' D&'$&4%&4 () *%3 /(*1X4,4&. B(O(B3@ +0)(*(0') &..0/&*3B
&) 834 *%3 A&)%Q33. #04 ?093' *0 ?04Q (' *%3 4,4&. B()*4(/*) &43 43X&..0/&*3B *0 U&.&.&-&B B,3
8&4*.1 *0 *%3 #&/* *%&* ?093' (' *%3 4,4&. B()*4(/*) &43 9043 )0/(&..1 43)*4(/*3B *%&' ?093' ('
U&.&.&-&B@ [' &BB(*(0'P ?093' ?04Q('$ #04 "D+ (' U&.&.&-&B &43 '0* &..0?3B *0 $0 *0 4,4&.
B()*4(/*) L,),&..1 -1 *%3(4 #&9(.(3)NP B,3 *0 /0'/34') &-0,* *%3 )3/,4(*1 )(*,&*(0'@
" #,4*%34 /0'/34' O0(/3B -1 80.(/393' *0?&4B) *%3(4 #39&.3 /0..3&$,3) ?&) *%&* B3)8(*3 *%3
?093'S) &..3$3B.1 ('#34(04 834#049&'/3 &'B .0? .3O3.) 0# .(*34&/1P *%31 ?343 84090*3B
'3O34*%3.3))@ A%3 43)3'*93'* &-0,* ?093'S) 84090*(0' &883&4) *0 -3 -&)3B 0' *%3 /%&4$3
*%&* *34 & 834(0B 0# &40,'B *%433 13&4) ?04Q('$ (' *%3 )&93 80)(*(0'P ?093' &43&,*09&*(/&..1 84090*3B (' 4&'Q &'B )&.&41 -,* ?(*%0,* 43&..1 /%&'$('$ *%3(4 80)(*(0'@ ['
/0'*4&)*P 93' /&' 0'.1 -3 84090*3B 0'/3 & ),(*&-.3 80)(*(0' -3/093) &O&(.&-.3@ nd [* ?&) #,4*%34
)*&*3B *%&* ?093' /0,.B '0* -3 B()/(8.('3BP &) *%31 ?0,.B .3&O3 *%3(4 80)(*(0' (')*&'*.1 (# *0.B *0
&-(B3 -1 *%3 )&93 4,.3) &) 93'@ ne 7093 80.(/393' ),$$3)*3B *%&* *%3 8004 834#049&'/3 0#
80.(/3?093' ?&) & 840B,/* 0# *%3 ?093' %&O('$ *0 &**3'B *0 *%3(4 B093)*(/ 0-.($&*(0') &'B
B,*(3) ('/.,B('$ %&O('$ *0 /&43 #04 10,'$ /%(.B43'@ ng
:$1"##$%7,.'"%4
[' &BB(*(0' *0 ('/43&)('$ )&.&4(3)P ),8804*('$ .(*34&/1 *4&('('$P &44&'$('$ B3B(/&*3B
*4&')804*&*(0'P 840O(B('$ &884084(&*3 &'B #39&.3 #4(3'B.1 #&/(.(*(3)P *4&')8&43'* &'B *(93.1
84090*(0' 93/%&'()9)P &'0*%34 Q31 43/0993'B&*(0' ?&) /.0)34 ?04Q('$ 43.&*(0')%(8 ?(*%
.0/&. 43.($(0,) .3&B34)@ A%3 ),8804* 0# *%3 43.($(0,) .3&B34) ?&) )&(B *0 -3 (')*4,93'*&. #04
('/43&)3B &//38*&'/3 0# &'B 43)83/* #04 ?093' ?04Q('$ (' "D+ -1 *%3 $3'34&. 8,-.(/ &'B *%3(4
9&.3 /0..3&$,3)@ ".)0P *0 &BB43)) *%3 ('&B3\,&/1 0# #39&.3 ,'(#049) (* ?&) ),$$3)*3B *%&*
n= T0')04*(,9 +&4*'34)S #33B-&/Q )3))(0' &* *%3 "#$%&' M093' 7Q(..) &'B E3O3.0893'* T3'*34P H3-4,&41:gP :;
-
8/11/2019 Women in ANP - A Baseline Assessment
44/73
???@&8840@04$@ =`
?093' )%0,.B -3 $(O3' *%3 #&-4(/ )0 *%31 /&' %&O3 *%3(4 0?' ,'(#049) 9&B3P ?%(/% ?0,.B
9&Q3 *%3 ,'(#049) 9,/% -3**34 #(**('$ *%&' 93'S) 0.B ,'(#049)@ ni
ni D"D
-
8/11/2019 Women in ANP - A Baseline Assessment
45/73
???@&8840@04$@ ==
3,/5+
b&.Q% ?&) O()(*3B B,4('$ U&',&41 0(' *%3 80.(/3 ?&) -&)3B
84(9&4(.1 0' 3/0'09(/ /0')(B34&*(0'@ A0 O&41('$ B3$433) *%3 80.(/3?093' &'B 80.(/393'
('*34O(3?3B &.. 3f843))3B /0'#(B3'/3 *%&* *%3 "#$%&' D&*(0'&. "491 L"D"N ?(.. -3 &-.3 *0
9&('*&(' )3/,4(*1 (' *%3 80)*X:;01) & /098&4&*(O3.1 %($%34 .3O3. 0# )3/,4(*1 *%&' 0*%34 840O('/(&. /&8(*&.)@
+0.(/3?093' &43 &-.3 *0 &**3'B 3O3'('$ /.&))3) &'B 90O3 #433.1 ?(*%0,* 9&.3 /098&'1@
nn b"G
-
8/11/2019 Women in ANP - A Baseline Assessment
46/73
???@&8840@04$@ =d
7,484()('$.1P *%3 &**(*,B3 0# *%3 80.(/393' (' J&6&4X3 7%&4(# ?&) 43804*3B *0 -3 .3)) #&O04&-.3
*0?&4B *%3(4 #3..0? #39&.3 /0..3&$,3) ?%3' /098&43B *0 *%3 &**(*,B3) 0# *%3 80.(/393' ('
V34&* &'B W,'B,6@
!"#$% '% (-02 09;N"4$c 0$;1$N.'"% ,%7 a$%7$;$7 Z'))$;$%1$4
A%3 40.3 0# *%3 80.(/3 ?&) O(3?3B &) 0'3 0# #($%*('$ *34404()9P 9&('*&('('$ *%3 4,.3 0# .&?P
/0'B,/*('$ /4(9('&. ('O3)*($&*(0'P $&('('$ *%3 *4,)* -1 *43&*('$ 8308.3 ?(*% 43)83/* &'B
840*3/*('$ /(O(.(&')@ 5'3 43)80'B3'* B3)/4(-3B *%3 80.(/3 &) *%3 93B(&*04 -3*?33' *%3
$0O34'93'* &'B (*) 8308.3 B3)8(*3 *%3 #&/* *%&* *%343 ?343 )($'(#(/&'* 840-.39) 0# *4,)*
-3*?33' *%3 8308.3 &'B *%3 $0O34'93'* &'B (*) 80.(/3 #04/3@
-
8/11/2019 Women in ANP - A Baseline Assessment
47/73
???@&8840@04$@ =e
0;"4N$1.4
A%343 () )093 &//38*&'/3 0# ?093' ?04Q('$ #04 *%3 80.(/3 -1 9&'1 0# *%3 #&9(.(3) 0# *%3
80.(/3?093'@ ") ?(*% *%3 0*%34 840O('/3) O()(*3B #04 *%() 43)3&4/%P *%343 () &.)0 43/0$'(*(0' 0#
*%3 /4,/(&. 40.3 8.&13B -1 ?093' (' (9840O('$ *%3 3##3/*(O3'3)) 0# *%3 80.(/3@ ,B(/(&.
)1)*39 &'B .3$&. 840/3))3)@ T4(9('&. ('O3)*($&*(0'P %0,)3 )3&4/%3)P ,)3 0# %&'B #(43&49) &'B
)3.#XB3#3')3 /0,4)3) &43 840O(B3B 84(04 *0 -3('$ /099())(0'3B@ 5'3 0# *%3 ?093' 43)80')(-.3#04 #39&.3 43/4,(*93'* 43/3(O3B & )/%0.&4)%(8 *0 43/3(O3 *4&('('$ (' Y$18* ?%(.3 )(f 0*%34) ?343
)3'* *0 W14$16)*&' #04 *4&('('$@ M093' &43 &.)0 $(O3' 08804*,'(*(3) *0 &**3'B '($%* )/%00.)@ 04 /%&..3'$3 ?(*% *%3 .0?34 .(*34&/1 4&*3 #04 ?093'P %0?3O34R
: 4"A$ #&/$)+28 +.; "/4$) /)+&.&.* E# 2"./&.9$ %" /4+/ /4$ A"#&2$E"-$.
E# #$+). /4)"9*4 )$A$/&/&".>
Q M+#$ W00&2$) B T+#O4
>+,//$%*$4
7(9(.&4 *0 W&-,.P D&'$&4%&4 &'B W,'B,6P *%3 80.(/3?093' ('*34O(3?3B /098.&('3B &-0,*
('&B3\,&*3 ,'(#049)P &'B 9())('$ 3\,(893'*P .0? )&.&4(3) L& /098.&('* &.)0 9&B3 -1
80.(/393'NP &'B .&/Q 0# 84090*(0' 08804*,'(*(3) (' /09-('&*(0' ?(*% ('),##(/(3'* ',9-34 0#
#39&.3XB3)($'&*3B %($% 4&'Q('$ 80)(*(0') (' *%3 A&)%Q33.@
-
8/11/2019 Women in ANP - A Baseline Assessment
48/73
-
8/11/2019 Women in ANP - A Baseline Assessment
49/73
???@&8840@04$@ =i
" 43/0993'B&*(0' )*43))3B (' b&.Q% (' 8&4*(/,.&4 ?&) *0 (9840O3 *%3 /,443'* 8&/Q&$3 0#
('/3'*(O3)P 3@$@P .,98 ),9 8&193'*) #04 B3&*%) (' *%3 #&9(.1 0# "D+ 834)0''3.@
-
8/11/2019 Women in ANP - A Baseline Assessment
50/73
???@&8840@04$@ =n
W$;,.
V34&* ?&) O()(*3B B,4('$ U&',&41
-
8/11/2019 Women in ANP - A Baseline Assessment
51/73
???@&8840@04$@ d;
!"#$% '% (-02 09;N"4$c 0$;1$N.'"% ,%7 a$%7$;$7 Z'))$;$%1$4
A%3 90)* (9804*&'* *&)Q #04 "D+ ?&) )&(B *0 -3 #($%*('$ *34404()9 &'B 9&('*&('('$ *%3 4,.3 0#
.&?@ J0)* 0# *%0)3 ('*34O(3?3B ?343 ,'#&9(.(&4 ?(*% ('*34'&*(0'&. 04 '&*(0'&. 840*0/0.) &'B
.3$().&*(0'@ ['*34'&*(0'&. /0'O3'*(0')P 0('('$ *%3 80.(/3 %&O3 *0 ,'B34$0 & )34(3) 0# *4&('('$)@ ".. *%0)3
('*34O(3?3B )&(B *%&* *%31 %&B 43/3(O3B *&)QX)83/(#(/ *4&('('$ 84(04 *0 >0('('$@ 5*%34 *4&('('$
840$4&9) #04 *%3 3'*(43 80.(/3 #04/3 ?343 )&(B *0 ('/.,B3 %,9&' 4($%*)P /098,*34 *4&('('$P ,)('$
4&B(0 /099,'(/&*(0' &'B /4(9('&. ('O3)*($&*(0'@ A%3 ?093' ?04Q('$ #04 *%3 H2C %&B 43/3(O3B
#,4*%34 *4&('('$ 0' )83/(#(/ '&*(0'&. .&?) ),/% &) *%3 Ya"M .&? &'B ?343 *%,) Q'0?.3B$3&-.3
&-0,* *%3 /0'*3'*) 0# Ya"M (' /0'*4&)* *0 *%3(4 9&.3 /0..3&$,3)@
-
8/11/2019 Women in ANP - A Baseline Assessment
52/73
???@&8840@04$@ d :0 /4$)$ &% +. &.2&;$./ /4+/ 4+% /" L$ )$A")/$; /" V+L9#C /4$)$ &% ." +2/&@$ +.; )$#&+L#$
2"--9.&2+/&". #&.$ /" %$$O +;@&2$ +.; )$%A".; +AA)"A)&+/$#8 /" /4$ $@$./> M": %4"9#; /+O$
A)+2/&2+# -$+%9)$% /" )$-"@$ /4&% L+))&$) &. 356>b
Q M+#$ 7$.&") )+.O&.* "00&2$) B N$)+/
A%343 ?343 & ',9-34 0# 43#343'/3) *0 *%3 %($% .3O3. 0# /044,8*(0' &'B '380*()9 ?(*%(' "D+@
['*34O(3?33) 43804*3B *%&* 84090*(0') &'B *4&('('$ &-40&B ?343 &?&4B3B 0' *%3 -&)() 0#
834)0'&. #&O04) &'B $00B 43.&*(0') 4&*%34 *%&' 934(*@ +0.(/393' O0(/3B /098.&('*) &-0,*
?04Q('$ &**(*,B3) 0# ?093' &'B B()/4(9('&*(0' (' #&O04 0# ?093'P &..3$('$ *%&* 80.(/3?093'
43/3(O3B 9043 84090*(0') &'B .3)) B()/(8.('&41 &/*(0' #04 /09('$ *0 ?04Q .&*3 04 .3&O('$ 3&4.1P
#04 3f&98.3P *%&' 80.(/393'@ A%343 ?343 &.)0 &..3$&*(0')P -1 93'P 0# 904&..1 /044,8* -3%&O(04
-1 ?093'@
-
8/11/2019 Women in ANP - A Baseline Assessment
54/73
???@&8840@04$@ d`
0,* *0 *%3 C.39& T0,'/(. &'B 0*%34 43.($(0,) .3&B34) *0 /43&*3 & 80)(*(O3 (9&$3 0# *%3 80.(/3 &)
840O(B('$ & ,)3#,. )34O(/3 *0 *%3 $3'34&. 8,-.(/@
-
8/11/2019 Women in ANP - A Baseline Assessment
55/73
???@&8840@04$@ d=
=,8/$ RA E9##,;F ") T'%7'%*4!"#$% '% (-0 0;"4N$1.4 >+,//$%*$4 :$1"##$%7,.'"%
S9%79U X A%343 () &$3'34&. ?()% -180.(/3?093' *0 %&O39043 ?093' (' "D+@
X
+0.(/3?093' /&441 0,*&B9('()*4&*(O3 B,*(3)('/.,B('$ $3'34&.&B9('()*4&*(0'P43/4,(*93'*P &'B/098,*34 ?04Q@ A%31&.)0 ?04Q ('('*3..($3'/3 &'B('O3)*($&*(0')@ M093'B0 '0* *&Q3 8&4* ('#40'*.('3 #($%*('$ 04&493B /0'#40'*&*(0'@
X b0*%80.(/393' &'B80.(/3?093' ),8804*9043 ?093' (' "D+ 0'
*%3 /0'B(*(0' *%&*?093' 933* ?%&* ()43\,(43B 0# *%39 &'B&43 ),->3/* *0 *%3 )&93B()/(8.('&41 4,.3) &)93'@
X T%(3#T099&'B34 () O341),8804*(O3 0#80.(/3?093'@
X M093' &43'0* &(B *0 ?3&4 "D+,'(#049 (' 8,-.(/@
X J0)*
80.(/393' &'B ?093'?0,.B &8840O3 0# *%3(4#&9(.1 939-34) >0('('$"D+
X +40#3))(0'&.*4&('('$) %&O3 %&B &80)(*(O3 (98&/* 0'('/43&)('$ *%3&//38*&'/3 0# #39&.30##(/34) (' "D+
X A%343 () &'3$&*(O3 8,-.(/834/38*(0' 0# *%3 80.(/3@
X +0.(/3?093
' %&O3 .0? 904&.3@X A%343 () &.&/Q 0# #39&.3X#4(3'B.1?04Q('$ #&/(.(*(3)
X J0[ ('W&-,. () '0* 43)80')(O3*0 *%3 '33B) 0# "D+ ('W,'B,6@
X A%343 ()('&B3\,&*3*4&')804*&*(0' #0480.(/3?093'@
X "D+X840O(B3B *4&')804*&*(0'
() O(3?3B &) & )3/,4(*1*%43&*@
X ['/43&)3 *%3',9-34 0# #39&.3XB3)($'&*3B 80)(*(0') ('*%3 A&)%Q33.@
X
T&441 0,**&4$3*3B 43/4,(*93'*&(93B &* ('/43&)('$ *%3',9-34 0# 80.(/3?093'@
X T&441 0,*93B(& 0,*43&/% *0 &**4&/*?093' *0 ?04Q('$ ('"D+@
X ['/43&)3/004B('&*(0' -3*?33'W&-,. &'B W,'B,6@
X T&441 0,**%040,$% -&/Q$40,'B/%3/Q)@
S,89/ X M093'&43 )33' &) & /4,/(&.&))3* #04 "D+ ('B3&.('$ ?(*% #39&.3
O(/*(9) &'B83483*4&*04)@
X T0990'*&)Q) #04 80.(/3?093'&43 %0,)3 )3&4/%3) &'B0##(/3 B,*(3)@
X M093'&43 '0* &..0?3B *0/&441 .&4$3 #(43&49)&'B B0 '0* 8&4*(/(8&*3(' #40'*.('3) (' &493B/0'#40'*&*(0')@
X +0.(/3?093' B0 '0* B0 '($%*
)%(#*)
X A%343 ())093 Q'0?.3B$3 0#('*34'&*(0'&. 840*0/0.)?093'S) 4($%*) -,*
Ya"M () Q'0?' *0 90)*0# *%3 80.(/3?093'@
X 709380.(/3?093' &43 840,B0# -3('$ (' "D+@
X b0*%80.(/393' &'B80.(/3?093' *%('Q (* ()'3/3))&41 *0 %&O380.(/3?093' (' "D+@
X [..(*34&/1.3O3. &90'$)*80.(/3?093' () O341%($%@
X G(*34&/1/.&))3) &43 0##343B(443$,.&4.1@
X A%343 () &.&/Q 0# #39&.3X#4(3'B.1?04Q('$ #&/(.(*(3)@
X A%3,'(#049) $(O3' *080.(/3?093' &43('&B3\,&*3@
X +0.(/3?093' 3f834(3'/3 9(f3B)0/(&. &//38*&'/3@
X +4090*(0')&43 0'X8&834 0'.1P43),.*('$ (' B3/43&)3B.3$(*(9&/1 &'B .3))3'3B(98&/* 0# ?093' (' *%380.(/3@
X ['/43&)3 *%34&$3 0# *&)Q) &'B43)80')(-(.(*(3) #0480.(/3?093'@
X T43&*3 9043%($% .3O3. A&)%Q33.80)(*(0') #04 ?093'@
X [9840O3*4&')804*&*(0' #04 ?093'@
X Y'),43 *%&**%343 &43 ),##(/(3'* &'B&B3\,&*3 #39&.3X#4(3'B.1#&/(.(*(3)@
-,%*,;+,; X D"+M"&'B ('*34'&*(0'&. .3$&./0'O3'*(0') &43 .&4$3.1,'Q'0?'@
X +0.(/3?09
X 7093?093' &43 3'/0,4&$3B-1 *%3(4 #&9(.1 *0 >0('"D+@
X 7093
X D&'$&4%&4() *%3 90)* /%&..3'$('$0# d 840O('/3) B,3 *0 (*)%($%34 .3O3. 0# )0/(&./0')34O&*()9@
X 7&.&41 ('/43&)3) #04 ?093'X G(*34&/1 *4&('('$X E3B(/&*3B *4&')804*&*(0'X 7,8804* 0# 43.($(0,) .3&B34)X C'(#049)
-
8/11/2019 Women in ANP - A Baseline Assessment
56/73
???@&8840@04$@ dd
3' ?04Q &) -0B1)3&4/%34)P ('43/4,(*93'* &'B ('?093'S) )%3.*34)@
X +0.(/3?093' 43804* $00B43.&*(0') ?(*% 9&.3/0..3&$,3)@
X +0.(/393'%0.B & '3$&*(O3 O(3? 0#80.(/3?093' -3/&,)3*%31 O(3? ?093' &),'B34 \,&.(#(3B@
?093' >0(' "D+*%40,$% *%3(4 0?'('*343)*@
X T099,'(*13.B34) %&O3 ).0?.1&//38*3B *%3 (B3& 0#%&O('$ 80.(/3?093' ('"D+@
X 70/(&./0')34O&*()9 B3/43&)3).(Q3.(%00B 0# &//38*&'/30# ?093' (' "D+@
X 23.&*(O3.1%($%34 80))(-(.(*1 0#B3)*&-(.(6&*(0' () &/0'/34'@
X J0)*80.(/3?093' 843*3'B*%31 %&O3 0*%34 >0-)@
X M093'083'.1 &B9(* *0 -3('$&(B 0# 8%1)(/&.&**&/Q)@
X 23.($(0,).3&B34) &'B 80.(/393'&43 $3'34&..1,'),8804*(O3 0# ?093'(' "D+@
X D3$&*(O3O(3? -1 80.(/393' 0#80)(*(O3 B()/4(9('&*(0'(' #&O0,4 0#80.(/3?093'@
3,/5+ X A%343 () &$3'34&..1 80)(*(O3834/38*(0' 0#80.(/3?093' (' "D+-3/&,)3 80.(/3?093'/&' %&O3 )0/(&..1&//38*&-.3 &//3)) *0?093' ('O0.O3B ('/4(93@
X +0.(/3?093' &43 )093*(93)&))($'3B *0%0,)3Q338('$ B,*(3)(')*3&B 0# B3)($'&*3B#,'/*(0')@
X 23.&*(0')-3*?33' 80.(/393' &'B80.(/3?093' &43 9(f3B?(*% )093 43804*('$ (*&) $00B ?%(.3 0*%34) B0'0*@
X A%343 ()43/0$'(*(0' *%&* ?093'%&O3 9&B3 80)(*(O3/0'*4(-,*(0') *0 "D+@
X A%343 () &),-)*&'*(&. &90,'* 0#*4&('('$ 08804*,'(*(3) #04?093'@
X J0B34&*3/0'*&/* (' )0/(&.0//&)(0') 0,*)(B3 0# ?04Q() 43804*3B -3*?33'80.(/3?093' &'B80.(/393'@
X +0.(/3?093' %&O3 .0?34 .3O3.) 0#.(*34&/1 &'B \,&.(#(/&*(0'*%&' 80.(/393'@
X +0.(/3?093' /098.&(' &-0,*,'(#049) &'B .&/Q 0#3\,(893'*@
X ^3'34&./098.&('*) &-0,* .0?)&.&4(3) L#04 80.(/3?093'&'B 80.(/393'N@
X M04Q('$904&.3 0# 80.(/3?093' ())33' &) .0? -1 *%3(4),834(04 0##(/34)@
X V($%34 .3O3.0# )3f,&. %&4&))93'* ()43804*3B (' /098&4()0'*0 *%3 0*%34 840O('/3)@
X M093' B0'0* ,)3 *%3 "D+X840O(B3B*4&')804*&*(0'@
X b,(.B 9043#39&.3X#4(3'B.1 #&/(.(*(3)@
X 7,)*&('*4&('('$ 3##04*) #0480.(/3?093'@
X ['/43&)3-3'3#(*) 8&/Q&$3)@
W$;,.X A%343 () &
$3'34&. )3'*(93'* *%&*80.(/393' &'B80.(/3?093' )%0,.B%&O3 *%3 )&9343)80')(-(.(*(3)@
X M093')%0,.B '0* 3'$&$3 ('#40'*.('3 #($%*('$@
X 23.&*(0')
X ".. ?093'?04Q('$ #04 "D+ ,'B34$0*&)QX)83/(#(/ *4&('('$@
X H2C %&)-33' *4&('3B 0' *%3Ya"M .&?@
X V($%344&'Q('$ ?093' %&O3&//3)) *0 *4&')804*&*(0'@
X H&9(.(3)
X A%343 &43/098.&('*) &-0,*('&B3\,&*3 ,'(#049)@
X A%343 &43('),##(/(3'* ',9-34 0#80)(*(0') (' *%3 A&)%Q33.*0 9&*/% *%3 &/*,&.',9-34 0# 80.(/3?093'@
X J0[ ()43804*3B *0 -3
X A%343 )%0,.B-3 9043 )*4&*3$(/P*&4$3*3B 0,*43&/% *0&**4&/* ?093' *0 >0('('$"D+@
X J3B(&/&98&($'('$ *0 43/4,(*?093' *0 "D+ )%0,.B -3('*3')(#(3B@
X T(*1X4,4&.
-
8/11/2019 Women in ANP - A Baseline Assessment
57/73
???@&8840@04$@ de
-3*?33' 80.(/393' &'B80.(/3?093' &4343804*3B &) $00B@
X A%343 &43)093 43804*) 0# 3*%'(/B()/4(9('&*(0' &'B)3f,&. %&4&))93'*@
&'B .0/&. /099,'(*(3)&43 ('/43&)('$.1),8804*(O3 0#80.(/3?093'@
X T099,'(*13.B34) ),8804*80.(/3?093'@
,'43)80')(O3 *0 *%3'33B) 0# "D+ (' V34&*@
X A%343 &4343804*) 0# /044,8*(0' &'B'380*()9@
X +0.(/393'/098.&(' &-0,*B()/4(9('&*(0' (' #&O0,40# ?093'@
X +0.(/3?093' 43804* 43/3(O('$*%43&*)@
X A%343 &43)093 43804*) 0# )3f,&.%&4&))93'* 0#80.(/3?093' -1 9&.3/0..3&$,3)@
B(O(B3 )%0,.B -3&BB43))3B@
X A%343 )%0,.B-3 & %3&.*% ('),4&'/3 8.&'@
X T&)3) 0#,'B3)(4&-.3 /0'B,/*)%0,.B -3 43O(3?3B 9043/&43#,..1 *0 &O0(BO(/*(9(6&*(0' 0#80.(/3?093'@
X +.&/3 9043?093' (' *%3 T099&'B34(' T%(3#S) 0##(/3@
-
8/11/2019 Women in ANP - A Baseline Assessment
58/73
???@&8840@04$@ dg
S$F T'%7'%*4 ,%7 >"%1/94'"%
M(*%(' *%3 .&)* g 13&4) *%3 &-)0.,*3 ',9-34 0# 80.(/3?093' %&) ('/43&)3B -1 &-0,* *3'#0.B@A%3 0O34&.. ',9-34 0# ?093' ?04Q('$ (' *%3 80.(/3 &) 43804*3B -1 *%3 J0'(*04('$ C'(* *0 *%3
J('()*41 0# ['*34(04 ()
-
8/11/2019 Women in ANP - A Baseline Assessment
59/73
???@&8840@04$@ di
" 9&(' 3f8.&'&*(0' #04 *%3 ).0? )833B (' &**4&/*('$ ?093' *0 "D+ () *%3 9&'1 9()834/38*(0')
0# *%3 $3'34&. 8,-.(/ 43$&4B('$ *&)Q) &'B 8,480)3) 0# #39&.3 80.(/3@ " >0- &* *%3 80.(/3 43\,(43)
93' &'B ?093' ?04Q('$ *0$3*%34 (' 0'3 0##(/3P 0#*3' ,'B34 8004.1 840O()(0'3B &'B ('&B3\,&*3
/0'B(*(0')@ A%3)3 /0'B(*(0') 0#*3' 43),.* (' ('O0.,'*&41 9(f('$ 0# 9&.3 &'B #39&.3 80.(/3
834)0''3. &'B #33B ('*0 8,-.(/ 834/38*(0' 0# h(9904&. -3%&O(04S &* *%3 ?04Q8.&/3@ 2,904) &'B
&..3$&*(0') 0# h904&. /044,8*(0'S 0# 80.(/3?093' &.)0 9&Q3 >0-) ?(*% "D+ ,'B3)(4&-.3 #04
3B,/&*3B ?093'@
A%343 () & 834)()*3'* .&/Q 0# *4,)* -3*?33' *%3 8,-.(/ &'B *%3 80.(/3 B,3 *0 *%3 *&('*3B 40.3 0#
*%3 '&*(0'&. 80.(/3 #04/3 (' *%3 80.(*(/&. %()*041 "#$%&'()*&'@ A%343 /0'*(',3) *0 -3 & $3'34&.
B()*4,)* 0# *%3 8,-.(/ (' "D+@
-
8/11/2019 Women in ANP - A Baseline Assessment
60/73
???@&8840@04$@ dn
840-.39 0# ('),##(/(3'* %($%X4&'Q('$ #39&.3 80.(/3 () #04 J0[ *0 ('/43&)3 *%3 ',9-34 0# A&)%Q33.
80)(*(0') 3&49&4Q3B #04 ?093' &'B 8,-.(/(63 O&/&'* 80)(*(0') #04 ?093' 9043 &$$43))(O3.1P
),8804*3B -1 & 8,-.(/ &?&43'3)) /&98&($') &) ),$$3)*3B -1 & ',9-34 0# ('*34O(3?33) (' V34&*@
b0*% 93' &'B ?093' *%0,$%* 0# *%() )*4&*3$1 &) 3##3/*(O3 (' 9&Q('$ *%3 80.(/('$ )*4,/*,43)
9043 83493&-.3 &'B ),)*&('&-.3 #04 ?093'@ [' W&-,. &'B V34&* *%3 834)0''3. #409 *%3
43/4,(*93'* B38&4*93'*) )*&*3B *%&* 9043 ?093' ?0,.B >0(' *%3 80.(/3 (# *%343 ?343 80)(*(0')
&O&(.&-.3@ ^(O3' *%3 $3'34&. B(##(/,.*(3) (' &**4&/*('$ ?093' *0 >0(' "D+P *%() () & )($'(#(/&'*
#('B('$ #04 8.&') *0 ('/43&)3 *%3 ',9-34 0# ?093' (' "D+ '&*(0'&..1@ [* () #&4 #409 /.3&4P
%0?3O34P ?%3*%34 (' /(*(3) ),/% &) W,'B,6 &' ('/43&)3 0# *%3)3 80)(*(0') (' *%3 A&)%Q33. ?(..
%&O3 *%3 B3)(43B (98&/* )('/3 W,'B,6 %&) '0* 13* -33' &-.3 *0 #(.. *%3 /,443'* 80)(*(0')
&..0/&*3B #04 ?093' ?(*% \,&.(#(3B /&'B(B&*3)@ 7(9(.&4.1P (* () B0,-*#,. ?%3*%34 &.. ?093' *%&*
%&O3 43$()*343B &' ('*343)* (' >0('('$ "D+ (' W&-,. &'B V34&* &43 \,&.(#(3B *0 #(.. %($%X4&'Q('$80)(*(0')@
5#*3' *%3 0'.1 ?&1 #04 ?093' *0 $3* 84090*3B 04 $&(' &//3)) *0 #,4*%34 -3'3#(*) &883&4) *0 -3
*%40,$% 834)0'&. 43.&*(0')@ A%3 843O&.3'/3 0# '380*()9 () 0#*3' /&,)3 #04 &..3$&*(0') 0# h904&.
/044,8*(0'SP 8&4*(/,.&4.1 (# *%3 -3'3#(/(&41 () #39&.3@
-
8/11/2019 Women in ANP - A Baseline Assessment
61/73
???@&8840@04$@ e;
()),3@ 23804*('$ &'B ('O3)*($&*('$ %&4&))93'* /&)3) () & /0'*3'*(0,) ()),3 *%&* '33B) *0 -3
%&'B.3B ?(*% /&43@
H,4*%34 /098.&('*) O0(/3B &$&(')* ?093' ?04Q('$ (' *%3 80.(/3P 3)83/(&..1 )*43))3B ('
D&'$&4%&4P W&-,. &'B b&.Q%P 43#34 *0 *%3(4 ?04Q 3*%(/)@ A%() 0#*3' 43#34) *0 80.(/3?093' /09('$
*0 ?04Q .&*3 &'B .3&O('$ 3&4.1 ?%(.3 )093 ?093' ?0,.B '3O34 /093 *0 ?04Q #04 *%3(4 )%(#*)@
A%() /4(*(/()9 () O0(/3B *0$3*%34 ?(*% /%&4$3) 0# ,'B34X\,&.(#(/&*(0' &'B %($% 4&*3) 0# (..(*34&/1
&90'$ *%3 80.(/3?093' (' /098&4()0' *0 9&.3 /0..3&$,3)@ +40O()(0' 0# /%(.B/&43 #&/(.(*(3)P
&B3\,&*3 *4&')804*P &'B .(*34&/1 /0,4)3) #04 ?093'P &//098&'(3B ?(*% &?&43'3)) 4&()('$
/0,4)3) #04 93'P ?0,.B $0 & .0'$ ?&1 (' &..3O(&*('$ *%3)3 43)3'*93'*)@
M%(.)* ?093' /098.&('3B &-0,* .&/Q 0# 84090*(0')P 90)* 80.(/393' 9&('*&('3B *%&* /4(9('&.('O3)*($&*(0' &'B %($%34 *%&' DT5 80)(*(0') 43\,(43 & /34*&(' .3O3. 0# 3B,/&*(0' *%&* ?093'
/,443'*.1 .&/Q@ A%3 80.(/3?093' 43804*3B *%&* *%31 ?343 ,'&-.3 *0 &**3'B *%3 840O(B3B .(*34&/1
/.&))3) 90)* 0# *%3 *(93)P B,3 *0 .&/Q 0# #39&.3 /0..3&$,3) *&Q('$ 0O34 *%3 >0- ?%(.3 *%31 ?343
$0'3@ G(*34&/1 /0,4)3) #04 #39&.3 80.(/3 )%0,.B *%,) -3 &B&8*3B *0 ?093'S) '33B) &'B
),88.393'*3B ?(*% *&)Q)X43.&*3B )Q(..) *4&('('$@
M093' #409 ,4-&' /3'*34) &43 ,),&..1 '0* &..0?3B -1 *%3(4 #&9(.(3) *0 ?04Q (' 4,4&. &43&)@ "*
*%3 )&93 *(93 ?093' (' 4,4&. &43&) &43 '0* &..0?3B -1 *%3(4 9043 /0')34O&*(O3 #&9(.(3) *0 ?04Q
#04 *%3 80.(/3@ A0 933* *%3 A&)%Q33. \,0*& #04 *%3 4,4&. &43&)P ?093' &43 398.013B (' *%3
840O('/(&. /3'*34 -,* ?(*% 43)80')(-(.(*(3) (' *%3 4,4&. B()*4(/*) *%&* /&''0* -3 #,.#(..3B@ A%3 4,4&.X
,4-&' B(O(B3 )3393B .3)) )($'(#(/&'* (' W,'B,6P ?%343 ?093' 43804*3B.1 ?343 ?04Q('$ (' *%3
4,4&. B()*4(/*) &'B 0'3 B()*4(/* /099&'B34 43804*3B *%&* %3 ?&) (' *%3 840/3)) 0# 43/4,(*('$ '('3
&BB(*(0'&. ?093'@ "BB(*(0'&. *4&('('$P 93'*04('$P &'B 8,-.(/ &?&43'3)) /&98&($') /&' -3 ,)3B
*0 43B,/3 *%3 ,4-&'X4,4&. B(O(B3@
H('&..1P *%343 () *%3 9&>04 /%&..3'$3 0# /0')()*3'/1 (' 840$4&99('$ -1 *%3 *?0 9&('
('*34'&*(0'&. &/*04) /%&4$3B ?(*% 43#049('$ &'B -,(.B('$ "D+@ YC+5G &'B ^349&'1S) #0/,) 0'
/099,'(*1 80.(/('$ '33B) *0 -3 43/0'/(.3B ?(*% DAJX"FT7ATX" 8&4&9(.(*&41 F /0,'*34
('),4$3'/1 &8840&/%@ M%(.3 *%343 () '0 (993B(&*3 43/0993'B&*(0' 0' %0? *%3 *?0 9&('
('*34'&*(0'&. &/*04) /&' B0 & -3**34 >0- 0# /004B('&*(0'P %&O('$ 9043 #43\,3'* B(&.0$,3 0'
-
8/11/2019 Women in ANP - A Baseline Assessment
62/73
???@&8840@04$@ e"%4";.'9# J,%7,.$ ,%7 J$#8$;4
A%3 +0.(/3 M093' J3'*04)%(8 +40$4&9 ()
-
8/11/2019 Women in ANP - A Baseline Assessment
73/73
A%3 +MJ+ T0')04*(,9 398.01) #(O3 *183) 0# &/*(O(*(3) &) #0..0?)R
(!(:C-CEE2 A%40,$% &?&43'3)) 4&()('$ *%3 *&)Q) &'B (9804*&'/3 0# 80.(/3?093' (' *%3"#$%&' D&*(0'&. +0.(/3 () &(93B *0 ('/43&)3 (' /099,'(*(3) &'B *%3 80.(/3@ A%343-1P *%3Q'0?.3B$3 0# %0? *0 &//3)) 80.(/3?093' &'B ,*(.(63 ?(*%(' &//3)) *0 >,)*(/3 &'B .&?3'#04/393'* ?(.. -3 ('/43&)3B@ b1 93&') 0# 3B,/&*(0'&. )3))(0')P B()/,))(0') &'B B())39('&*(0'0# /&98&($'('$ 9&*34(&.) /0980'3'*) 0'3 &'B *?0 ?(.. -3 &BB43))3B@
(ZL(>e2 "BO0/&/1 ?(.. -3 (98.393'*3B (' 04B34 *0 &))()* ?093' (' *%3 80.(/3 #04/3 ('(98.393'*('$ *%3(4 >0- &'B -3('$ -3**34 &//38*3B -1 *%3 /099,'(*(3)@ A%40,$% 80.(/3 ('*34'&.&BO0/&/1 *%3 80)(*(0'('$ 0# ?093' &'B *%3(4 *&)Q &..0/&*(0' () *&4$3*3B *0 (9840O3@ [' 04B34 *0B0 )0P *%3 /099&'B34 (' /%(3#P %3&B) 0# H2CP T[EP 43/4,(*93'* B38&4*93'*) &'B 43843)3'*&*(O3)0# *%3 J('()*41 0# ['*34(04 "##&(4) ?(.. -3 &8840&/%3B@ Yf*34'&. &BO0/&/1 () /0'B,/*3B ?(*% %($%X4&'Q('$ $0O34'93'* 0##(/(&.) ),/% &) *%3 840O('/(&. $0O34'04 &'B B()*4(/* $0O34'04) 0##(/3)P840O('/(&. /0,'/(.) &'B 840O('/(&. B38&4*93'*) ),/% &) E0M"P E38&4*93'* 0# V&> &'B J('()*410# U,)*(/3 &'B (' /099,'(*(3)@ A%40,$% &BO0/&/1 /0980'3'*) *?0 &'B #0,4 ?(.. -3 &BB43))3B@
JC-=